← SynDRA
TECARFARIN
SynDRA canonical compound SYN0031535 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | VKORC1 |
|---|
| Mechanism of action | vitamin k antagonist |
|---|
| Indication | thrombosis |
|---|
| Disease area | hematology |
|---|
All known targets
Mechanisms of action (all sources)
- VKORC1 INHIBITOR
- Vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor
- vitamin k antagonist
Cross-references
Synonyms
- Tecarfarine
- Tecarfarina
- ATI-5923
- ATI 5923
- WN1479YT50
- ATI5923
- tecarfarinum
- RefChem:891271
- DTXCID20158279
- Tecarfarin [USAN]
- Tecarfarin [USAN:INN]
- UNII-WN1479YT50
- TECARFARIN [INN]
- Tecarfarin (USAN/INN)
- TECARFARIN [WHO-DD]
- orb1706562
- SCHEMBL1647984
- SCHEMBL29379481
- QFLNTQDOVCLQKW-UHFFFAOYSA-N
- C21H14F6O5
- MFCD16620516
- AKOS030535872
- SB18978
- HY-14854
- MS-28430
- DB-225826
- CS-0003597
- NS00071039
- D09676
- G13886
- T17025
- تکارفارین
- Tecarfarin Sodium
- DA-67676
- HY-14854A
- tecarfarin sodium
- T17024
- DTAROZQXDYVCQR-UHFFFAOYSA-M
- D09677
Look up TECARFARIN in the interactive SynDRA portal →